Sutro Biopharma, Inc. (STRO)
Market Open
11 Sep, 14:01
$
17. 89
+0.06
+0.3085%
$
194.22M Market Cap
- P/E Ratio
- Div Yield
9,237 Volume
-3.14 Eps
$ 17.83
Previous Close Investors:
Want to track STRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sutro Biopharma, Inc. (STRO) Statistics
Valuation metrics
Market Cap 194.22M
Enterprise value 150.67M
Trailing P/E (ttm) -1.15
Forward P/E -13.99
PEG ratio -0.04
Price/Sales (ttm) 4.25
Price/Book (mrq) -3.22
Enterprise Value/Revenue 3.3
Enterprise Value/EBITDA -1.12
Overview
Shares outstanding 8.58M
Float 14.25M
Shares short 748.7K
% Held by insiders 0.02%
% Held by institutions 0.44%
Average volume (10 days) 143.33K
Average volume (90 days) 223.07K
Price summary
52-Week low 7.15
52-Week high 43.85
Beta 1.31
50-Day moving average 22.57
200-Day moving average 27.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Dec 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -3.95%
Operating margin -3.1%
Operational effectiveness
Return on assets -0.93%
Return on equity 1.85%
Income Statement
Revenue (ttm) 102.48M
Revenue per share (ttm) 2.76
Quarterly revenue growth (yoy) -0.21%
Gross profit (ttm) -63.93M
EBITDA -97.63M
Net income to common (ttm) -191.09M
Diluted EPS (ttm) -10.9
Quarterly earnings growth (yoy) -0.21%
Balance Sheet
Total cash (mrq) 141.43M
Total cash per share (mrq) 9.92
Total debt (mrq) 15.67M
Total Debt/Equity (mrq) -0.1
Current ratio (mrq) 3.32%
Book value per share (mrq) -6.23
Cash Flow
Cash flow statement -177.23M
Levered free cash flow (LFCF) -112.39M
